spatial transcriptomics geomx Search Results


90
Spatial Transcriptomics Inc geomx spatial transcriptomics
Geomx Spatial Transcriptomics, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx/pm39846634-101-14-15
Average 90 stars, based on 1 article reviews
geomx spatial transcriptomics - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx® digital spatial profiler (dsp)
Geomx® Digital Spatial Profiler (Dsp), supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+digital+spatial+profiler/pmc09401975__mmc1-87-19-0
Average 90 stars, based on 1 article reviews
geomx® digital spatial profiler (dsp) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx v2.5
Geomx V2.5, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+v2+5/pmc11189406__41467_2024_49524_MOESM11_ESM-9-8-14
Average 90 stars, based on 1 article reviews
geomx v2.5 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx dsp set
<t>GeoMx</t> spatial profiling reveals pro-inflammatory conversion of TAMs in DC patients (A) Schematic for GeoMx spatial transcriptomics profiling of pre- and post-treatment biopsies from non-DC (n = 3 patients, 30 ROIs) and DC (n = 3 patients, 33 ROIs) patients. Representative images of morphology marker staining and corresponding segmentation are displayed for a single ROI. (B) Volcano plot showing differentially expressed genes in DC patient CD68 + areas after bexmarilimab therapy. (C) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of DC patients after bexmarilimab therapy (gene set enrichment analysis). (D) Volcano plot showing differentially expressed genes in non-DC patient CD68 + areas after bexmarilimab therapy. (E) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of non-DC patients after bexmarilimab therapy (gene set enrichment analysis). (F) Heatmap of M1 and M2 macrophage gene scores on CD68 + area. Red color indicates higher M1 or M2 gene expression than overall gene expression, blue color lower. Each tile represents median of patient’s ROIs. (G) Bar graph of M2/M1 score ratios corresponding to scores shown in (F). Each point represents patient median across ROIs and each bar patient group median. (H) Volcano plot showing differentially activated pathways between CD68 + areas of non-DC and DC patients’ pre-treatment biopsies (gene set enrichment analysis, n = 16 ROIs [non-DC], n = 10 ROIs [DC]). Pre, pre-treatment biopsy; Post, post-treatment biopsy; ROI, region of interest; P adj , Benjamini-Hochberg-adjusted p value; ∗∗ P adj < 0.01; ∗ P adj < 0.05; ns, not significant. In (C) and (E), red color denotes pathway activation and blue downregulation. See also <xref ref-type=Figures S7 – , and Supplementary and . " width="250" height="auto" />
Geomx Dsp Set, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+dsp+set/pmc10772343-433-0-10
Average 90 stars, based on 1 article reviews
geomx dsp set - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx dsp
<t>GeoMx</t> spatial profiling reveals pro-inflammatory conversion of TAMs in DC patients (A) Schematic for GeoMx spatial transcriptomics profiling of pre- and post-treatment biopsies from non-DC (n = 3 patients, 30 ROIs) and DC (n = 3 patients, 33 ROIs) patients. Representative images of morphology marker staining and corresponding segmentation are displayed for a single ROI. (B) Volcano plot showing differentially expressed genes in DC patient CD68 + areas after bexmarilimab therapy. (C) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of DC patients after bexmarilimab therapy (gene set enrichment analysis). (D) Volcano plot showing differentially expressed genes in non-DC patient CD68 + areas after bexmarilimab therapy. (E) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of non-DC patients after bexmarilimab therapy (gene set enrichment analysis). (F) Heatmap of M1 and M2 macrophage gene scores on CD68 + area. Red color indicates higher M1 or M2 gene expression than overall gene expression, blue color lower. Each tile represents median of patient’s ROIs. (G) Bar graph of M2/M1 score ratios corresponding to scores shown in (F). Each point represents patient median across ROIs and each bar patient group median. (H) Volcano plot showing differentially activated pathways between CD68 + areas of non-DC and DC patients’ pre-treatment biopsies (gene set enrichment analysis, n = 16 ROIs [non-DC], n = 10 ROIs [DC]). Pre, pre-treatment biopsy; Post, post-treatment biopsy; ROI, region of interest; P adj , Benjamini-Hochberg-adjusted p value; ∗∗ P adj < 0.01; ∗ P adj < 0.05; ns, not significant. In (C) and (E), red color denotes pathway activation and blue downregulation. See also <xref ref-type=Figures S7 – , and Supplementary and . " width="250" height="auto" />
Geomx Dsp, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+dsp/pmc11867587-14-28-7
Average 90 stars, based on 1 article reviews
geomx dsp - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx-dsp data
<t>GeoMx</t> spatial profiling reveals pro-inflammatory conversion of TAMs in DC patients (A) Schematic for GeoMx spatial transcriptomics profiling of pre- and post-treatment biopsies from non-DC (n = 3 patients, 30 ROIs) and DC (n = 3 patients, 33 ROIs) patients. Representative images of morphology marker staining and corresponding segmentation are displayed for a single ROI. (B) Volcano plot showing differentially expressed genes in DC patient CD68 + areas after bexmarilimab therapy. (C) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of DC patients after bexmarilimab therapy (gene set enrichment analysis). (D) Volcano plot showing differentially expressed genes in non-DC patient CD68 + areas after bexmarilimab therapy. (E) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of non-DC patients after bexmarilimab therapy (gene set enrichment analysis). (F) Heatmap of M1 and M2 macrophage gene scores on CD68 + area. Red color indicates higher M1 or M2 gene expression than overall gene expression, blue color lower. Each tile represents median of patient’s ROIs. (G) Bar graph of M2/M1 score ratios corresponding to scores shown in (F). Each point represents patient median across ROIs and each bar patient group median. (H) Volcano plot showing differentially activated pathways between CD68 + areas of non-DC and DC patients’ pre-treatment biopsies (gene set enrichment analysis, n = 16 ROIs [non-DC], n = 10 ROIs [DC]). Pre, pre-treatment biopsy; Post, post-treatment biopsy; ROI, region of interest; P adj , Benjamini-Hochberg-adjusted p value; ∗∗ P adj < 0.01; ∗ P adj < 0.05; ns, not significant. In (C) and (E), red color denotes pathway activation and blue downregulation. See also <xref ref-type=Figures S7 – , and Supplementary and . " width="250" height="auto" />
Geomx Dsp Data, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+dsp+data/pmc11785740__41467_2025_56237_MOESM3_ESM-94-7-9
Average 90 stars, based on 1 article reviews
geomx-dsp data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Spatial Transcriptomics Inc platform geomx digital spatial profiler
A PULSE-CHASE iSILK paradigm. Experimental Design 1: PULSE period ( 15 N diet) between 6-10 months of age. Experimental Design 2: PULSE period between 6-10 months of age, CHASE period ( 14 N diet) between 10–18 months of age. Resulting Aβ1-42 MALDI MS isotopologue pattern that is right-shifted (Δm) due to increasing 15 N incorporation. B Representative images of plaque load from <t>GeoMx</t> whole slide scans, repeated on four independent whole-brain slices at 18-months and three at 10-months. C MALDI MSI single ion image of Aβ1-42 in cortex section. D Schematic overview of the correlative hyperspectral imaging and MALDI MSI experiment. 15 N enrichment (nitrogen index) was calculated as the AUC ratio of the 4th to 3rd peak in the Aβ1-42 isotopologue pattern. Higher values indicate greater 15 N incorporation. E Schematic overview of the correlative <t>spatial</t> <t>transcriptomics</t> (GeoMx) and MALDI MSI experiment. Stable 15 N enrichments (nitrogen index) corresponding to plaque age was calculated by extracting the FWHM of the Aβ1-42 peak, where a broader peak indicates increased 15 N incorporation and higher age. F Schematic overview of the validation experiment. Plaque morphology was evaluated by LCO hyperspectral imaging. IHC of selected proteins were correlated with plaque age, as evaluated by hyperspectral imaging. G Representative spectra from MALDI MSI showing the 14 N and 15 N-enriched Aβ1-42 m/z peak. H Aβ1-42 mass analysis comparing the plaque center (Cen) vs. the periphery (Peri) in 10-month-old mice ( p = 0.00017), ( I ) in 18-month-old mice ( p = 0.00000077), and ( J ) differences between cortex and hippocampus ( p = 0.022). H , I Linear Mixed Model accounting for across animals and repeated measures, point color indicates animal, 15 replicates over n = 3 m mice and 22 replicates over n = 4 m mice, respectively. J Two-sided Paired t-test, 22 replicates over n = 4 m mice, data presented as mean ± SEM. K Representative MALDI MSI image of 15 N and 14 N enriched Aβ1-42 distribution in plaques in 18-month-old mice. Parts of the figure created in BioRender. Szadziewska, A. ( https://BioRender.com/4qpojxz ) Image in ( E ) provided by Bruker Spatial Biology. Significance levels: *** P < 0.001, ** P < 0.01; * P < 0.05. Source data are provided as a Source Data file. FWHM full width at half maximum, RP reflector mode, LP linear mode.
Platform Geomx Digital Spatial Profiler, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/digital+geomx+platform+profiler+spatial/pmc12402145-122-3-1
Average 86 stars, based on 1 article reviews
platform geomx digital spatial profiler - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx rois
A PULSE-CHASE iSILK paradigm. Experimental Design 1: PULSE period ( 15 N diet) between 6-10 months of age. Experimental Design 2: PULSE period between 6-10 months of age, CHASE period ( 14 N diet) between 10–18 months of age. Resulting Aβ1-42 MALDI MS isotopologue pattern that is right-shifted (Δm) due to increasing 15 N incorporation. B Representative images of plaque load from <t>GeoMx</t> whole slide scans, repeated on four independent whole-brain slices at 18-months and three at 10-months. C MALDI MSI single ion image of Aβ1-42 in cortex section. D Schematic overview of the correlative hyperspectral imaging and MALDI MSI experiment. 15 N enrichment (nitrogen index) was calculated as the AUC ratio of the 4th to 3rd peak in the Aβ1-42 isotopologue pattern. Higher values indicate greater 15 N incorporation. E Schematic overview of the correlative <t>spatial</t> <t>transcriptomics</t> (GeoMx) and MALDI MSI experiment. Stable 15 N enrichments (nitrogen index) corresponding to plaque age was calculated by extracting the FWHM of the Aβ1-42 peak, where a broader peak indicates increased 15 N incorporation and higher age. F Schematic overview of the validation experiment. Plaque morphology was evaluated by LCO hyperspectral imaging. IHC of selected proteins were correlated with plaque age, as evaluated by hyperspectral imaging. G Representative spectra from MALDI MSI showing the 14 N and 15 N-enriched Aβ1-42 m/z peak. H Aβ1-42 mass analysis comparing the plaque center (Cen) vs. the periphery (Peri) in 10-month-old mice ( p = 0.00017), ( I ) in 18-month-old mice ( p = 0.00000077), and ( J ) differences between cortex and hippocampus ( p = 0.022). H , I Linear Mixed Model accounting for across animals and repeated measures, point color indicates animal, 15 replicates over n = 3 m mice and 22 replicates over n = 4 m mice, respectively. J Two-sided Paired t-test, 22 replicates over n = 4 m mice, data presented as mean ± SEM. K Representative MALDI MSI image of 15 N and 14 N enriched Aβ1-42 distribution in plaques in 18-month-old mice. Parts of the figure created in BioRender. Szadziewska, A. ( https://BioRender.com/4qpojxz ) Image in ( E ) provided by Bruker Spatial Biology. Significance levels: *** P < 0.001, ** P < 0.01; * P < 0.05. Source data are provided as a Source Data file. FWHM full width at half maximum, RP reflector mode, LP linear mode.
Geomx Rois, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+rois/pm38036767-221-222-212
Average 90 stars, based on 1 article reviews
geomx rois - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx dsp barcode
A PULSE-CHASE iSILK paradigm. Experimental Design 1: PULSE period ( 15 N diet) between 6-10 months of age. Experimental Design 2: PULSE period between 6-10 months of age, CHASE period ( 14 N diet) between 10–18 months of age. Resulting Aβ1-42 MALDI MS isotopologue pattern that is right-shifted (Δm) due to increasing 15 N incorporation. B Representative images of plaque load from <t>GeoMx</t> whole slide scans, repeated on four independent whole-brain slices at 18-months and three at 10-months. C MALDI MSI single ion image of Aβ1-42 in cortex section. D Schematic overview of the correlative hyperspectral imaging and MALDI MSI experiment. 15 N enrichment (nitrogen index) was calculated as the AUC ratio of the 4th to 3rd peak in the Aβ1-42 isotopologue pattern. Higher values indicate greater 15 N incorporation. E Schematic overview of the correlative <t>spatial</t> <t>transcriptomics</t> (GeoMx) and MALDI MSI experiment. Stable 15 N enrichments (nitrogen index) corresponding to plaque age was calculated by extracting the FWHM of the Aβ1-42 peak, where a broader peak indicates increased 15 N incorporation and higher age. F Schematic overview of the validation experiment. Plaque morphology was evaluated by LCO hyperspectral imaging. IHC of selected proteins were correlated with plaque age, as evaluated by hyperspectral imaging. G Representative spectra from MALDI MSI showing the 14 N and 15 N-enriched Aβ1-42 m/z peak. H Aβ1-42 mass analysis comparing the plaque center (Cen) vs. the periphery (Peri) in 10-month-old mice ( p = 0.00017), ( I ) in 18-month-old mice ( p = 0.00000077), and ( J ) differences between cortex and hippocampus ( p = 0.022). H , I Linear Mixed Model accounting for across animals and repeated measures, point color indicates animal, 15 replicates over n = 3 m mice and 22 replicates over n = 4 m mice, respectively. J Two-sided Paired t-test, 22 replicates over n = 4 m mice, data presented as mean ± SEM. K Representative MALDI MSI image of 15 N and 14 N enriched Aβ1-42 distribution in plaques in 18-month-old mice. Parts of the figure created in BioRender. Szadziewska, A. ( https://BioRender.com/4qpojxz ) Image in ( E ) provided by Bruker Spatial Biology. Significance levels: *** P < 0.001, ** P < 0.01; * P < 0.05. Source data are provided as a Source Data file. FWHM full width at half maximum, RP reflector mode, LP linear mode.
Geomx Dsp Barcode, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+dsp+barcode/10__1097_slash_hep__0000000000000866-250-16-26
Average 90 stars, based on 1 article reviews
geomx dsp barcode - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx immune pathways panel
A PULSE-CHASE iSILK paradigm. Experimental Design 1: PULSE period ( 15 N diet) between 6-10 months of age. Experimental Design 2: PULSE period between 6-10 months of age, CHASE period ( 14 N diet) between 10–18 months of age. Resulting Aβ1-42 MALDI MS isotopologue pattern that is right-shifted (Δm) due to increasing 15 N incorporation. B Representative images of plaque load from <t>GeoMx</t> whole slide scans, repeated on four independent whole-brain slices at 18-months and three at 10-months. C MALDI MSI single ion image of Aβ1-42 in cortex section. D Schematic overview of the correlative hyperspectral imaging and MALDI MSI experiment. 15 N enrichment (nitrogen index) was calculated as the AUC ratio of the 4th to 3rd peak in the Aβ1-42 isotopologue pattern. Higher values indicate greater 15 N incorporation. E Schematic overview of the correlative <t>spatial</t> <t>transcriptomics</t> (GeoMx) and MALDI MSI experiment. Stable 15 N enrichments (nitrogen index) corresponding to plaque age was calculated by extracting the FWHM of the Aβ1-42 peak, where a broader peak indicates increased 15 N incorporation and higher age. F Schematic overview of the validation experiment. Plaque morphology was evaluated by LCO hyperspectral imaging. IHC of selected proteins were correlated with plaque age, as evaluated by hyperspectral imaging. G Representative spectra from MALDI MSI showing the 14 N and 15 N-enriched Aβ1-42 m/z peak. H Aβ1-42 mass analysis comparing the plaque center (Cen) vs. the periphery (Peri) in 10-month-old mice ( p = 0.00017), ( I ) in 18-month-old mice ( p = 0.00000077), and ( J ) differences between cortex and hippocampus ( p = 0.022). H , I Linear Mixed Model accounting for across animals and repeated measures, point color indicates animal, 15 replicates over n = 3 m mice and 22 replicates over n = 4 m mice, respectively. J Two-sided Paired t-test, 22 replicates over n = 4 m mice, data presented as mean ± SEM. K Representative MALDI MSI image of 15 N and 14 N enriched Aβ1-42 distribution in plaques in 18-month-old mice. Parts of the figure created in BioRender. Szadziewska, A. ( https://BioRender.com/4qpojxz ) Image in ( E ) provided by Bruker Spatial Biology. Significance levels: *** P < 0.001, ** P < 0.01; * P < 0.05. Source data are provided as a Source Data file. FWHM full width at half maximum, RP reflector mode, LP linear mode.
Geomx Immune Pathways Panel, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+immune+pathways+panel/pm35988589-206-8-0
Average 90 stars, based on 1 article reviews
geomx immune pathways panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Spatial Transcriptomics Inc geomx digital spatial profiler whole-transcriptome atlas (wta) assay
A PULSE-CHASE iSILK paradigm. Experimental Design 1: PULSE period ( 15 N diet) between 6-10 months of age. Experimental Design 2: PULSE period between 6-10 months of age, CHASE period ( 14 N diet) between 10–18 months of age. Resulting Aβ1-42 MALDI MS isotopologue pattern that is right-shifted (Δm) due to increasing 15 N incorporation. B Representative images of plaque load from <t>GeoMx</t> whole slide scans, repeated on four independent whole-brain slices at 18-months and three at 10-months. C MALDI MSI single ion image of Aβ1-42 in cortex section. D Schematic overview of the correlative hyperspectral imaging and MALDI MSI experiment. 15 N enrichment (nitrogen index) was calculated as the AUC ratio of the 4th to 3rd peak in the Aβ1-42 isotopologue pattern. Higher values indicate greater 15 N incorporation. E Schematic overview of the correlative <t>spatial</t> <t>transcriptomics</t> (GeoMx) and MALDI MSI experiment. Stable 15 N enrichments (nitrogen index) corresponding to plaque age was calculated by extracting the FWHM of the Aβ1-42 peak, where a broader peak indicates increased 15 N incorporation and higher age. F Schematic overview of the validation experiment. Plaque morphology was evaluated by LCO hyperspectral imaging. IHC of selected proteins were correlated with plaque age, as evaluated by hyperspectral imaging. G Representative spectra from MALDI MSI showing the 14 N and 15 N-enriched Aβ1-42 m/z peak. H Aβ1-42 mass analysis comparing the plaque center (Cen) vs. the periphery (Peri) in 10-month-old mice ( p = 0.00017), ( I ) in 18-month-old mice ( p = 0.00000077), and ( J ) differences between cortex and hippocampus ( p = 0.022). H , I Linear Mixed Model accounting for across animals and repeated measures, point color indicates animal, 15 replicates over n = 3 m mice and 22 replicates over n = 4 m mice, respectively. J Two-sided Paired t-test, 22 replicates over n = 4 m mice, data presented as mean ± SEM. K Representative MALDI MSI image of 15 N and 14 N enriched Aβ1-42 distribution in plaques in 18-month-old mice. Parts of the figure created in BioRender. Szadziewska, A. ( https://BioRender.com/4qpojxz ) Image in ( E ) provided by Bruker Spatial Biology. Significance levels: *** P < 0.001, ** P < 0.01; * P < 0.05. Source data are provided as a Source Data file. FWHM full width at half maximum, RP reflector mode, LP linear mode.
Geomx Digital Spatial Profiler Whole Transcriptome Atlas (Wta) Assay, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/geomx+digital+spatial+profiler+whole+transcriptome+atlas++wta++assay/pm38036767-186-27-0
Average 90 stars, based on 1 article reviews
geomx digital spatial profiler whole-transcriptome atlas (wta) assay - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Spatial Transcriptomics Inc geomx rna assay
A PULSE-CHASE iSILK paradigm. Experimental Design 1: PULSE period ( 15 N diet) between 6-10 months of age. Experimental Design 2: PULSE period between 6-10 months of age, CHASE period ( 14 N diet) between 10–18 months of age. Resulting Aβ1-42 MALDI MS isotopologue pattern that is right-shifted (Δm) due to increasing 15 N incorporation. B Representative images of plaque load from <t>GeoMx</t> whole slide scans, repeated on four independent whole-brain slices at 18-months and three at 10-months. C MALDI MSI single ion image of Aβ1-42 in cortex section. D Schematic overview of the correlative hyperspectral imaging and MALDI MSI experiment. 15 N enrichment (nitrogen index) was calculated as the AUC ratio of the 4th to 3rd peak in the Aβ1-42 isotopologue pattern. Higher values indicate greater 15 N incorporation. E Schematic overview of the correlative <t>spatial</t> <t>transcriptomics</t> (GeoMx) and MALDI MSI experiment. Stable 15 N enrichments (nitrogen index) corresponding to plaque age was calculated by extracting the FWHM of the Aβ1-42 peak, where a broader peak indicates increased 15 N incorporation and higher age. F Schematic overview of the validation experiment. Plaque morphology was evaluated by LCO hyperspectral imaging. IHC of selected proteins were correlated with plaque age, as evaluated by hyperspectral imaging. G Representative spectra from MALDI MSI showing the 14 N and 15 N-enriched Aβ1-42 m/z peak. H Aβ1-42 mass analysis comparing the plaque center (Cen) vs. the periphery (Peri) in 10-month-old mice ( p = 0.00017), ( I ) in 18-month-old mice ( p = 0.00000077), and ( J ) differences between cortex and hippocampus ( p = 0.022). H , I Linear Mixed Model accounting for across animals and repeated measures, point color indicates animal, 15 replicates over n = 3 m mice and 22 replicates over n = 4 m mice, respectively. J Two-sided Paired t-test, 22 replicates over n = 4 m mice, data presented as mean ± SEM. K Representative MALDI MSI image of 15 N and 14 N enriched Aβ1-42 distribution in plaques in 18-month-old mice. Parts of the figure created in BioRender. Szadziewska, A. ( https://BioRender.com/4qpojxz ) Image in ( E ) provided by Bruker Spatial Biology. Significance levels: *** P < 0.001, ** P < 0.01; * P < 0.05. Source data are provided as a Source Data file. FWHM full width at half maximum, RP reflector mode, LP linear mode.
Geomx Rna Assay, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spatial+transcriptomics+geomx/assay+geomx+rna/pm41324334-461-12-0
Average 86 stars, based on 1 article reviews
geomx rna assay - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


GeoMx spatial profiling reveals pro-inflammatory conversion of TAMs in DC patients (A) Schematic for GeoMx spatial transcriptomics profiling of pre- and post-treatment biopsies from non-DC (n = 3 patients, 30 ROIs) and DC (n = 3 patients, 33 ROIs) patients. Representative images of morphology marker staining and corresponding segmentation are displayed for a single ROI. (B) Volcano plot showing differentially expressed genes in DC patient CD68 + areas after bexmarilimab therapy. (C) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of DC patients after bexmarilimab therapy (gene set enrichment analysis). (D) Volcano plot showing differentially expressed genes in non-DC patient CD68 + areas after bexmarilimab therapy. (E) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of non-DC patients after bexmarilimab therapy (gene set enrichment analysis). (F) Heatmap of M1 and M2 macrophage gene scores on CD68 + area. Red color indicates higher M1 or M2 gene expression than overall gene expression, blue color lower. Each tile represents median of patient’s ROIs. (G) Bar graph of M2/M1 score ratios corresponding to scores shown in (F). Each point represents patient median across ROIs and each bar patient group median. (H) Volcano plot showing differentially activated pathways between CD68 + areas of non-DC and DC patients’ pre-treatment biopsies (gene set enrichment analysis, n = 16 ROIs [non-DC], n = 10 ROIs [DC]). Pre, pre-treatment biopsy; Post, post-treatment biopsy; ROI, region of interest; P adj , Benjamini-Hochberg-adjusted p value; ∗∗ P adj < 0.01; ∗ P adj < 0.05; ns, not significant. In (C) and (E), red color denotes pathway activation and blue downregulation. See also <xref ref-type=Figures S7 – , and Supplementary and . " width="100%" height="100%">

Journal: Cell Reports Medicine

Article Title: Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial

doi: 10.1016/j.xcrm.2023.101307

Figure Lengend Snippet: GeoMx spatial profiling reveals pro-inflammatory conversion of TAMs in DC patients (A) Schematic for GeoMx spatial transcriptomics profiling of pre- and post-treatment biopsies from non-DC (n = 3 patients, 30 ROIs) and DC (n = 3 patients, 33 ROIs) patients. Representative images of morphology marker staining and corresponding segmentation are displayed for a single ROI. (B) Volcano plot showing differentially expressed genes in DC patient CD68 + areas after bexmarilimab therapy. (C) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of DC patients after bexmarilimab therapy (gene set enrichment analysis). (D) Volcano plot showing differentially expressed genes in non-DC patient CD68 + areas after bexmarilimab therapy. (E) Bubble plots of top up- and downregulated pathways in CD68 + tumor areas of non-DC patients after bexmarilimab therapy (gene set enrichment analysis). (F) Heatmap of M1 and M2 macrophage gene scores on CD68 + area. Red color indicates higher M1 or M2 gene expression than overall gene expression, blue color lower. Each tile represents median of patient’s ROIs. (G) Bar graph of M2/M1 score ratios corresponding to scores shown in (F). Each point represents patient median across ROIs and each bar patient group median. (H) Volcano plot showing differentially activated pathways between CD68 + areas of non-DC and DC patients’ pre-treatment biopsies (gene set enrichment analysis, n = 16 ROIs [non-DC], n = 10 ROIs [DC]). Pre, pre-treatment biopsy; Post, post-treatment biopsy; ROI, region of interest; P adj , Benjamini-Hochberg-adjusted p value; ∗∗ P adj < 0.01; ∗ P adj < 0.05; ns, not significant. In (C) and (E), red color denotes pathway activation and blue downregulation. See also Figures S7 – , and Supplementary and .

Article Snippet: GeoMx DSP set (n = 6 patients; n = 180 spatial transcriptomics profiles) included all the patients who had paired pre- and post-treatment biopsies available, and had successful GeoMx DSP morphology staining and hybridization probe quantification.

Techniques: Marker, Staining, Gene Expression, Activation Assay

A PULSE-CHASE iSILK paradigm. Experimental Design 1: PULSE period ( 15 N diet) between 6-10 months of age. Experimental Design 2: PULSE period between 6-10 months of age, CHASE period ( 14 N diet) between 10–18 months of age. Resulting Aβ1-42 MALDI MS isotopologue pattern that is right-shifted (Δm) due to increasing 15 N incorporation. B Representative images of plaque load from GeoMx whole slide scans, repeated on four independent whole-brain slices at 18-months and three at 10-months. C MALDI MSI single ion image of Aβ1-42 in cortex section. D Schematic overview of the correlative hyperspectral imaging and MALDI MSI experiment. 15 N enrichment (nitrogen index) was calculated as the AUC ratio of the 4th to 3rd peak in the Aβ1-42 isotopologue pattern. Higher values indicate greater 15 N incorporation. E Schematic overview of the correlative spatial transcriptomics (GeoMx) and MALDI MSI experiment. Stable 15 N enrichments (nitrogen index) corresponding to plaque age was calculated by extracting the FWHM of the Aβ1-42 peak, where a broader peak indicates increased 15 N incorporation and higher age. F Schematic overview of the validation experiment. Plaque morphology was evaluated by LCO hyperspectral imaging. IHC of selected proteins were correlated with plaque age, as evaluated by hyperspectral imaging. G Representative spectra from MALDI MSI showing the 14 N and 15 N-enriched Aβ1-42 m/z peak. H Aβ1-42 mass analysis comparing the plaque center (Cen) vs. the periphery (Peri) in 10-month-old mice ( p = 0.00017), ( I ) in 18-month-old mice ( p = 0.00000077), and ( J ) differences between cortex and hippocampus ( p = 0.022). H , I Linear Mixed Model accounting for across animals and repeated measures, point color indicates animal, 15 replicates over n = 3 m mice and 22 replicates over n = 4 m mice, respectively. J Two-sided Paired t-test, 22 replicates over n = 4 m mice, data presented as mean ± SEM. K Representative MALDI MSI image of 15 N and 14 N enriched Aβ1-42 distribution in plaques in 18-month-old mice. Parts of the figure created in BioRender. Szadziewska, A. ( https://BioRender.com/4qpojxz ) Image in ( E ) provided by Bruker Spatial Biology. Significance levels: *** P < 0.001, ** P < 0.01; * P < 0.05. Source data are provided as a Source Data file. FWHM full width at half maximum, RP reflector mode, LP linear mode.

Journal: Nature Communications

Article Title: Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer’s disease mouse model

doi: 10.1038/s41467-025-63328-y

Figure Lengend Snippet: A PULSE-CHASE iSILK paradigm. Experimental Design 1: PULSE period ( 15 N diet) between 6-10 months of age. Experimental Design 2: PULSE period between 6-10 months of age, CHASE period ( 14 N diet) between 10–18 months of age. Resulting Aβ1-42 MALDI MS isotopologue pattern that is right-shifted (Δm) due to increasing 15 N incorporation. B Representative images of plaque load from GeoMx whole slide scans, repeated on four independent whole-brain slices at 18-months and three at 10-months. C MALDI MSI single ion image of Aβ1-42 in cortex section. D Schematic overview of the correlative hyperspectral imaging and MALDI MSI experiment. 15 N enrichment (nitrogen index) was calculated as the AUC ratio of the 4th to 3rd peak in the Aβ1-42 isotopologue pattern. Higher values indicate greater 15 N incorporation. E Schematic overview of the correlative spatial transcriptomics (GeoMx) and MALDI MSI experiment. Stable 15 N enrichments (nitrogen index) corresponding to plaque age was calculated by extracting the FWHM of the Aβ1-42 peak, where a broader peak indicates increased 15 N incorporation and higher age. F Schematic overview of the validation experiment. Plaque morphology was evaluated by LCO hyperspectral imaging. IHC of selected proteins were correlated with plaque age, as evaluated by hyperspectral imaging. G Representative spectra from MALDI MSI showing the 14 N and 15 N-enriched Aβ1-42 m/z peak. H Aβ1-42 mass analysis comparing the plaque center (Cen) vs. the periphery (Peri) in 10-month-old mice ( p = 0.00017), ( I ) in 18-month-old mice ( p = 0.00000077), and ( J ) differences between cortex and hippocampus ( p = 0.022). H , I Linear Mixed Model accounting for across animals and repeated measures, point color indicates animal, 15 replicates over n = 3 m mice and 22 replicates over n = 4 m mice, respectively. J Two-sided Paired t-test, 22 replicates over n = 4 m mice, data presented as mean ± SEM. K Representative MALDI MSI image of 15 N and 14 N enriched Aβ1-42 distribution in plaques in 18-month-old mice. Parts of the figure created in BioRender. Szadziewska, A. ( https://BioRender.com/4qpojxz ) Image in ( E ) provided by Bruker Spatial Biology. Significance levels: *** P < 0.001, ** P < 0.01; * P < 0.05. Source data are provided as a Source Data file. FWHM full width at half maximum, RP reflector mode, LP linear mode.

Article Snippet: The spatial transcriptomics platform GeoMx® Digital Spatial Profiler was selected over other sequencing techniques due to its ability to target plaque-specific gene expression changes, offering a more spatially resolved technique for AD pathology-associated alterations compared to the more commonly used RNA sequencing methods .

Techniques: Pulse Chase, Imaging, Biomarker Discovery